IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03157089Testing Afatinib in Combination With Pembrolizumab in Patients With Squamous Cell Carcinoma of the Lung